TY - JOUR
T1 - Resveratrol butyrate esters inhibit obesity caused by perinatal exposure to bisphenol a in female offspring rats
AU - Shih, Ming Kuei
AU - Tain, You Lin
AU - Chen, Yu Wei
AU - Hsu, Wei Hsuan
AU - Yeh, Yao Tsung
AU - Chang, Sam K.C.
AU - Liao, Jin Xian
AU - Hou, Chih Yao
N1 - Funding Information:
Funding: This research was funded by the Ministry of Science and Technology, Republic of China (grant Nos. 108-2221-E-992-046; 109-2221-E-992-051 and 110-2320-B-992-001-MY3), Kaohsiung Chang Gung Memorial Hospital, Taiwan (grant No. CORPG8L0301), and USDA-ARS SCA 5860667081.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - Resveratrol butyrate esters (RBE) are derivatives of resveratrol (RSV) and butyric acid and exhibit biological activity similar to that of RSV but with higher bioavailability. The aim of this study was designed as an animal experiment to explore the effects of RBE on the serum biochemistry, and fat deposits in the offspring rats exposed to bisphenol A (BPA), along with the growth and decline of gut microbiota. We constructed an animal model of perinatal Bisphenol A (BPA) exposure to observe the effects of RBE supplementation on obesity, blood lipids, and intestinal microbiota in female offspring rats. Perinatal exposure to BPA led to weight gain, lipid accumulation, high levels of blood lipids, and deterioration of intestinal microbiota in female offspring rats. RBE supplementation reduced the weight gain and lipid accumulation caused by BPA, optimised the levels of blood lipids, significantly reduced the Firmicutes/Bacteroidetes (F/B) ratio, and increased and decreased the abundance of S24-7 and Lactobacillus, respectively. The analysis of faecal short-chain fatty acid (SCFA) levels revealed that BPA exposure increased the faecal concentration of acetate, which could be reduced via RBE supplementation. However, the faecal concentrations of propionate and butyrate were not only significantly lower than that of acetate, but also did not significantly change in response to BPA exposure or RBE supplementation. Hence, RBE can suppress BPA-induced obesity in female offspring rats, and it demonstrates excellent modulatory activity on intestinal microbiota, with potential applications in perinatological research.
AB - Resveratrol butyrate esters (RBE) are derivatives of resveratrol (RSV) and butyric acid and exhibit biological activity similar to that of RSV but with higher bioavailability. The aim of this study was designed as an animal experiment to explore the effects of RBE on the serum biochemistry, and fat deposits in the offspring rats exposed to bisphenol A (BPA), along with the growth and decline of gut microbiota. We constructed an animal model of perinatal Bisphenol A (BPA) exposure to observe the effects of RBE supplementation on obesity, blood lipids, and intestinal microbiota in female offspring rats. Perinatal exposure to BPA led to weight gain, lipid accumulation, high levels of blood lipids, and deterioration of intestinal microbiota in female offspring rats. RBE supplementation reduced the weight gain and lipid accumulation caused by BPA, optimised the levels of blood lipids, significantly reduced the Firmicutes/Bacteroidetes (F/B) ratio, and increased and decreased the abundance of S24-7 and Lactobacillus, respectively. The analysis of faecal short-chain fatty acid (SCFA) levels revealed that BPA exposure increased the faecal concentration of acetate, which could be reduced via RBE supplementation. However, the faecal concentrations of propionate and butyrate were not only significantly lower than that of acetate, but also did not significantly change in response to BPA exposure or RBE supplementation. Hence, RBE can suppress BPA-induced obesity in female offspring rats, and it demonstrates excellent modulatory activity on intestinal microbiota, with potential applications in perinatological research.
UR - http://www.scopus.com/inward/record.url?scp=85110007899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85110007899&partnerID=8YFLogxK
U2 - 10.3390/molecules26134010
DO - 10.3390/molecules26134010
M3 - Article
C2 - 34209270
AN - SCOPUS:85110007899
SN - 1420-3049
VL - 26
JO - Molecules
JF - Molecules
IS - 13
M1 - 4010
ER -
